WIIK PHARMA ApS: Financial statements 2017
CVR: 36481315
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
WIIK PHARMA ApS (CVR 36481315) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,504,942 and a net result of DKK 274,190 compared with DKK 432,489 the year before. That is an increase of 5.4% compared with the year before. Equity in the 2017 report amounted to DKK 350,579. The solvency ratio was 12.8%.
- Gross Profit
- DKK 1,504,942
- Profit/Loss
- DKK 274,190
- Equity
- DKK 350,579
- Total Assets
- DKK 2,737,041
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.5 mio. | 274 t. | 351 t. | - |
| 2016 | - | 1.4 mio. | 432 t. | 76 t. | - |
| 2015 | - | 301 t. | -406 t. | -356 t. | - |
Official annual report
Keep an eye on WIIK PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
WIIK PHARMA ApS has published its annual report for 2016. Gross profit came to DKK 1,428,031, and the net result was DKK 432,489.
About WIIK PHARMA ApS
WIIK PHARMA ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rune Wiik Kristensen. The board consists of Bernt Skov Jensen (chair), Rune Wiik Kristensen and Yacoub Youssef Ibrahim Amin. The company is owned by Yacoub Amin Invest ApS and Wiik LLC. The company has 4 employees (2018). In 2025, the company reported a gross profit of DKK 7,105,582 and a net result of DKK 2,024,721 compared with DKK 4,385,191 the year before. Equity in the 2025 report amounted to DKK 6,710,672.